IPG-TRAMADOL/ACET 325 MG
ACETAMINOPHEN : 325 MG TRAMADOL HYDROCHLORIDE : 37.5 MG · DIN 02387123 · MARCAN PHARMACEUTICALS INC
Health Canada status: APPROVED
What is IPG-TRAMADOL/ACET?
IPG-TRAMADOL/ACET 325 MG contains ACETAMINOPHEN : 325 MG TRAMADOL HYDROCHLORIDE : 37.5 MG. It is listed in the Health Canada Drug Product Database under DIN 02387123, held by MARCAN PHARMACEUTICALS INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as approved, status dated 07-Jan-2016. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02387123 |
|---|---|
| Brand name | IPG-TRAMADOL/ACET |
| Generic / active ingredient | ACETAMINOPHEN : 325 MG TRAMADOL HYDROCHLORIDE : 37.5 MG |
| Manufacturer | MARCAN PHARMACEUTICALS INC |
| Strength | 325 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NARCOTICS (CDSA I) |
| ATC code | N02AJ13 TRAMADOL AND PARACETAMOL |
| AHFS class | 28:08.08 ; 28:08.92 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 07-Jan-2016 |
What can be used instead?
Other Canadian products sharing ATC code N02AJ13 TRAMADOL AND PARACETAMOL. 8 of 24 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-TRAMADOL/ACET | 325 MG | TABLET | APOTEX INC | MARKETED | DIN 02336790 |
| AURO-TRAMADOL/ACETAMINOPHEN | 37.5 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02439050 |
| JAMP-ACET-TRAMADOL | 325 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02388308 |
| MAR-TRAMADOL/ACET | 37.5 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02388324 |
| MINT-TRAMADOL/ACET | 325 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02389800 |
| PRZ-TRAMADOL/ACET | 325 MG | TABLET | PHARMARIS CANADA INC | MARKETED | DIN 02551047 |
| TARO-TRAMADOL/ACET | 37.5 MG | TABLET | SUN PHARMA CANADA INC | MARKETED | DIN 02388197 |
| TEVA-TRAMADOL/ACETAMINOPHEN | 325 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02347180 |
| ACT TRAMADOL/ACET | 37.5 MG | TABLET | ACTAVIS PHARMA COMPANY | CANCELLED POST MARKET | DIN 02383209 |
| AG-ACET-TRAMADOL | 325 MG | TABLET | ANGITA PHARMA INC. | APPROVED | DIN 02477092 |
Who else supplies TRAMADOL AND PARACETAMOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TRAMADOL AND PARACETAMOL appears in 695 registered pack listings across 13 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.